2023 Form 5500 filing — West Pharmaceutical Services, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240719101510NAL0003827907001) for West Pharmaceutical Services, Inc. 401(K) Plan, reported by West Pharmaceutical Services, Inc. under EIN 23-1210010 and plan number 008. It reports 5,550 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20240719101510NAL0003827907001
Filing year
2023
Form type
2
Plan sponsor
West Pharmaceutical Services, Inc.
EIN
23-1210010
Plan number
008
Location
Exton, PA
Participants
5,550
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$470,946,877
Total liabilities (EOY)
$0
Net assets (EOY)
$470,946,877
Employer contributions
$21,675,004
Participant contributions
$23,582,868
Total income / additions
$138,166,101
Benefits paid
$79,380,938
Administrative expenses
$179,745
Total expenses
$79,566,017
Net increase / (decrease)
$58,600,084
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalRECORDKEEPER$39,898not reported in the loaded dataset

Related Form 5500 pages